Skip to Content

Zoetis Inc Class A

ZTS: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$896.00KdxrdHsglhyjdd

Zoetis Earnings: Librela Gets Off to Strong Start in U.S., but Simparica Trio Faces More Competition

Wide-moat Zoetis delivered fourth-quarter and full-year results that met our expectations on the top line and slightly exceeded our bottom-line projections. After minor adjustments to our model that were immaterial, we’re holding steady on our fair value estimate. Quarterly operational revenue growth of 8% offered a strong finish to 2023 where operational sales grew 7%. In particular, the companion animal segment grew 10% on an operational basis in the fourth quarter—outpacing the market. Further, quarterly livestock revenue increased 6% off a relatively soft prior-year period, which added some topspin.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of ZTS so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center